News | July 25, 2011

New Release of Treatment Planning System Increases Efficiency

July 18, 2011 — The new releases of Elekta's XiO treatment planning system and Focal contouring system (v. 4.62) will enable clinicians to develop and deliver radiation therapy plans more efficiently.

The XiO enhancements include an improved intensity modulated radiation therapy (IMRT) segmentation algorithm, fluence map smoothing and DICOM dose import via Focal. Focal now provides improved tools for contouring, enabling clinicians to contour anatomy faster and more easily. Together, these new XiO and Focal features contribute to an approximate 30 percent reduction in segments and approximate 20 percent reduction in IMRT monitor units (MU)*, which translates into lower integral dose and faster treatment times.

Focal 4.62 now also features plan summation for any number of plans, allowing physicians to determine the cumulative dosimetric effects. The summed dose from multiple plans can be saved into a single plan.

In addition, the planning and contouring improvements support Elekta linear accelerators using MLCi2, which allows for multiple apertures and potentially fewer MUs to be delivered to the patient.  

*Data collected by Elekta on Smart Sequencing compared to step-and-shoot XiO plans.

For more information: www.elekta.com

 

Related Content

For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...
Minimizing delays to treatment could improve cancer survival rates, say researchers

Getty Images

News | Radiation Oncology | November 10, 2020
November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% high
In this retrospective cohort study of men with low-risk prostate cancer followed up for a median of 7.6 years, African American men, compared with non-Hispanic White men, had a statistically significant increased 10-year cumulative incidence of disease progression and definitive treatment, but not metastasis or prostate cancer–specific mortality

Getty Images

News | Prostate Cancer | November 04, 2020
November 4, 2020 — Previous studies have shown that African American men are 2.4 times as likely to die from...